{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-7782", "postId": 7782, "name": "agilon health, inc.", "description": "Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (\u201cagilon\u201d or the \u201cCompany\u201d) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware; (2) Defendants materially overstated the immediate positive financial impact from \u201cstrategic actions\u201d taken by agilon to reduce risk; and (3) as a result, defendants\u2019 statements about agilon\u2019s business, operations, and prospects were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. Lead Plaintiff Deadline: March 2, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "AGL", "legal": { "court": "United States District Court for the Eastern District of New York", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "02/26/2025", "end": "08/04/2025" }, "leadPlaintiffDeadline": "03/02/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/agilon-health-inc/", "canonicalUrl": "https://faruqilaw.com/case/agilon-health-inc/", "datePublished": "2026-01-05T16:01:36+00:00", "dateModified": "2026-01-15T18:41:13+00:00", "associatedOrganization": { "@id": "case-7782-org" }, "legalService": { "@id": "case-7782-legalservice" }, "hasPart": [ { "@id": "case-7782-faq" }, { "@id": "case-7782-press-list" } ], "legalRepresentation": [ { "@id": "case-7782-attorney-516" }, { "@id": "case-7782-attorney-506" } ] }, { "@type": "Organization", "@id": "case-7782-org", "name": "agilon health, inc.", "identifier": "AGL", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.agilonhealth.com/" }, { "@type": "LegalService", "@id": "case-7782-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-7782-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-7782-legalservice" } }, { "@type": "Person", "@id": "case-7782-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-7782-legalservice" } }, { "@type": "FAQPage", "@id": "case-7782-faq", "mainEntity": [ { "@type": "Question", "name": "What is the agilon health (AGL) securities class action lawsuit about?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges agilon health and its executives issued misleading 2025 financial guidance and overstated the success of \"strategic actions\" meant to reduce risk. Investors claim the company ignored industry headwinds, leading to inflated stock prices and subsequent financial losses." } }, { "@type": "Question", "name": "What is the deadline to join the agilon health class action as a lead plaintiff?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who suffered losses on agilon health (AGL) stock have until March 2, 2026, to move the court to serve as lead plaintiff. This role allows a shareholder to represent the class and direct the litigation against the company for alleged federal securities law violations." } }, { "@type": "Question", "name": "Which law firm is investigating potential claims against agilon health?", "acceptedAnswer": { "@type": "Answer", "text": "Faruqi & Faruqi, LLP, a national securities law firm, is currently investigating potential claims and representing shareholders in the federal class action against agilon health (AGL). They are looking into whether the company made false or misleading statements regarding its operations." } }, { "@type": "Question", "name": "Why did agilon health (AGL) stock price drop according to the lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint suggests the stock dropped when the \"true details\" of agilon\u2019s business prospects reached the market. It argues that previous positive statements about 2025 guidance and risk-reduction strategies were materially false, causing damages to shareholders once the reality was revealed." } }, { "@type": "Question", "name": "How do I know if I am eligible for the agilon health investor settlement?", "acceptedAnswer": { "@type": "Answer", "text": "Eligibility typically depends on whether you purchased agilon health (AGL) shares during the period when the allegedly false statements were made. If you suffered a financial loss, you can contact investigating firms like Faruqi & Faruqi to discuss your legal rights before the March 2 deadline." } } ] }, { "@type": "NewsArticle", "@id": "case-7782-press-1", "headline": "INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health", "url": "https://www.globenewswire.com/news-release/2026/01/14/3218902/683/en/INVESTOR-NOTICE-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-agilon-health.html", "datePublished": "2026-01-14" }, { "@type": "NewsArticle", "@id": "case-7782-press-2", "headline": "agilon health stock plunges after CEO steps down amid earnings miss", "url": "https://www.globenewswire.com/news-release/2026/01/14/3218902/683/en/INVESTOR-NOTICE-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-agilon-health.html", "datePublished": "2025-08-04" }, { "@type": "ItemList", "@id": "case-7782-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-7782-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-7782-press-2" } } ] } ] }

agilon health, inc.

agilon health, inc.

Join Action
Case Details
Filed On: January 5, 2026
Ticker AGL
Class Period 02/26/2025 - 08/04/2025
Lead Plaintiff Deadline 03/02/2026
Days Left to Seek Plaintiff
28

If you are an agilon health investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware; (2) Defendants materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk; and (3) as a result, defendants’ statements about agilon’s business, operations, and prospects were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

📞 Lead Plaintiff Deadline: March 2, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
agilon health, inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771